Mostrar el registro sencillo

dc.contributor.authorCañada-García, Javier E.es_ES
dc.contributor.authorMoure, Zairaes_ES
dc.contributor.authorSola-Campoy, Pedro J.es_ES
dc.contributor.authorDelgado-Valverde, Mercedeses_ES
dc.contributor.authorCano García, María Eliezeres_ES
dc.contributor.authorGijón, Desirèees_ES
dc.contributor.authorGonzález, Mónicaes_ES
dc.contributor.authorGracia-Ahufinger, Irenees_ES
dc.contributor.authorLarrosa, Nieveses_ES
dc.contributor.authorMulet, Xavieres_ES
dc.contributor.authorPitart, Cristinaes_ES
dc.contributor.authorRivera, Albaes_ES
dc.contributor.authorBou, Germánes_ES
dc.contributor.authorCalvo, Jorgees_ES
dc.contributor.authorCantón, Rafaeles_ES
dc.contributor.authorGonzález-López, Juan Josées_ES
dc.contributor.authorMartínez-Martínez, Luises_ES
dc.contributor.authorNavarro, Ferránes_ES
dc.contributor.authorOliver, Antonioes_ES
dc.contributor.authorPalacios-Baena, Zaira R.es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-12-02T14:53:51Z
dc.date.available2022-12-02T14:53:51Z
dc.date.issued2022-06-30es_ES
dc.identifier.issn1664-302Xes_ES
dc.identifier.urihttps://hdl.handle.net/10902/26803
dc.description.abstractObjectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3.es_ES
dc.description.sponsorshipFunding: This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014– 2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work. Acknowledgments: We thank all participating hospitals and the Genomics Unit of the Centro Nacional de Microbiología for support with DNA sequencing.es_ES
dc.format.extent13 p.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Research Foundationes_ES
dc.rightsAttribution 4.0 International*
dc.rights© 2022 The authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceFrontiers in microbiology June 2022 Volume 13 Article 918362es_ES
dc.titleCARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumonia e and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3389/fmicb.2022.918362es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3389/fmicb.2022.918362es_ES
dc.type.versionpublishedVersiones_ES
dc.description.otherCARB-ES-19 studyes_ES
dc.description.otherKlebsiella pneumoniaees_ES
dc.description.otherCarbapenemaseses_ES
dc.description.otherHigh-risk cloneses_ES
dc.description.otherWhole genome sequencinges_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International